Using the CBCT of the XRAD225Cx preclinical irradiator, 8 tissue equivalent cylinders of known composition and density (Gammex RMI, Middelton, WI) were imaged at 40kVp. The HU variation was plotted versus the product ρ times Zeff that yielded to a monotonically increasing curve. Based on this relationship and the tissues defined in the ICRU-44 report, interpolated tissues were created for ρZeff varying from 2 up to 27 with a 0.2 step. Tissue equivalent cylinders were irradiated with the XRAD225Cx (225kVp). Exit dose was measured with EBT3 films and compared to Monte Carlo (MC) calculations from our GATE model of the irradiator. On the CT images, tissue segmentation was performed either by manual assignation of the elemental composition provided by the manufacturer or by using the (HU, ρ, EC) method. Dosimetric impact of the (HU, ρ, EC) method was evaluated on mice CT comparing with manual segmentation for brain and femoral head irradiations. Results: Tissue equivalent exit dose measurements relative to solid water varied from 1.13 (AP6 adipose) down to 0.36 (SB3 cortical bone). Max 2% deviation was found with MC dose calculation performed with manufacturer data and 4.3% with calculation performed with the (HU, ρ, EC) method. Mean deviations were respectively 1.1% and 1.8%. It must be noticed that the segmentation method was based on real human tissues defined in ICRU-44 whereas measurements were performed with substitutes with elemental composition slightly different from human tissue elemental composition. The (HU, ρ, EC) method applied on mice CT allowed the automatic definition of 125 tissues. Dosimetric impact of the (HU, ρ, EC) was significant for bony tissues (>25%). Conclusions: A robust tissue segmentation method was developed for dose calculation in preclinical radiation therapy based on the (HU, ρZ eff ) relationship. Our method was successfully tested by comparing exit dose measurements from materials of known composition with MC dose calculation. The method was applied on mice CT for brain and femoral head irradiation with significant dosimetric impact.
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Urethra-sparing prostatic SBRT: extreme dosimetric optimization on rectal wall using an endorectal balloon A. Dubouloz 1 , L. Tsvang 2 , W. Verbakel 3 , M. Björkqvist 4 , N. Linthout 5 , D. Linero 6 , M. Rouzaud 1 , J. Lencart 7 , J.M. Pérez-Moreno 8 , Z. Ozen 9 , L. Purpose/Objective: To estimate the dosimetric impact of an endorectal balloon (ERB) on rectal wall (Rwall) dose distribution when using extreme dose constraints during the optimization of urethra-sparing prostatic SBRT plans. Materials and Methods: A total of ten cT1/3a N0 M0 prostate cancer patients, prospectively randomized in an European multicenter phase II trial of urethra-sparing SBRT, were simulated with and without a 100cc inflated ERB. Patients were treated with the ERB following a SBRT protocol of 36.25 Gy in 5 fractions of 7.25 Gy to the PTV. The dose prescribed to the prostatic urethra (urethral planning risk volume, uPRV) was reduced to 32.5 Gy. The dose was delivered with two full rotational volumetric modulated arcs. Ten plans with ERB and ten without (Vmat ref ) were first optimized until dose prescription and normal-tissue constraints (ranging from 50% to 100% of prescribed dose) specified in the protocol were reached. Additional optimizations based on these 20 Vmat ref plans were calculated by adding dose constraints to the posterior Rwall (D 3% , D 10% and D 20% ). Starting from Vmat ref (with and without ERB), these dose constraints were lowered five times to obtain plans Vmat 1 to Vmat 5 . A total of 120 plans were analyzed. The homogeneity index (HI) for the PTV and uPRV were calculated to determine which optimization better spared Rwall without degrading the coverage of target volumes. 
